Abstract

Mantle cell lymphoma is a B cell malignancy in which constitutive dysregulation of cyclin D1 and the cell cycle, disruption of DNA damage response pathways, and activation of cell survival mechanisms contribute to oncogenesis. A small number of tumors lack cyclin D1 overexpression, suggesting that its dysregulation is always not required for tumor initiation. Some cases have hypermutated IGHV and stable karyotypes, a predominant nonnodal disease, and an indolent clinical evolution, which suggests that they may correspond to distinct subtypes of the disease. In this review, we discuss the molecular pathways that contribute to pathogenesis, and how improved understanding of these molecular mechanisms offers new perspectives for the treatment of patients.

Keywords

Mantle cell lymphomaPathogenesisCyclin D1BiologyCarcinogenesisCancer researchMalignancyCell cycleLymphomaDiseaseCellDNA damageImmunologyPathologyGeneticsMedicineDNACancer

Affiliated Institutions

Related Publications

Publication Info

Year
2012
Type
review
Volume
122
Issue
10
Pages
3416-3423
Citations
367
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

367
OpenAlex

Cite This

Pedro Jares, Dolors Colomer, Elı́as Campo (2012). Molecular pathogenesis of mantle cell lymphoma. Journal of Clinical Investigation , 122 (10) , 3416-3423. https://doi.org/10.1172/jci61272

Identifiers

DOI
10.1172/jci61272